Skip to search formSkip to main contentSkip to account menu

4-azido-N-methylspiperone

Known as: 4-azidomethylspiperone 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Spiperone
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Difference in in vivo receptor binding between [3 H]N-methylspiperone and [3 H]raclopride in reserpine-treated mouse brain
The in vivo binding of [3 H]N-methylspiperone (NMSP) and [3 H]raclopride was compared in mice treated with reserpine (5 mg/kg, 24… 
2002
2002
Effects of rolipram on in vivo dopamine receptor binding
Summary. In order to clarify whether changes in brain concentrations of the second messenger cyclic AMP (cAMP) affect in vivo… 
2001
2001
Neuroimaging in Chronic MAP Users
Chronic use of methamphetamine (MAP) produces persistent psychiatric symptoms in some users. Here, we present our four major… 
1999
1999
Discrepancies in apparent dopamine D2 receptor occupancy between 3H-raclopride and 3H-N-methylspiperone
Summary. Competitive inhibition of 3H-raclopride (RAC) and 3H-N-methylspiperone (NMSP) binding against haloperidol, raclopride… 
1999
1999
Enhancement of 3H-N-methylspiperone binding but not 3H-raclopride binding in mouse striatum by MK-801: evidence that factors other than competition by endogenous dopamine are responsible for changes…
Summary. The effect of acute pretreatment with MK-801 on the binding in vivo of both 3H-N-methylspiperone (NMSP) and 3H… 
1993
1993
Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone.
Positron emission tomography (PET) with 11C-N-methylspiperone as the radioligand was carried out in 25 chronic schizophrenic… 
1991
1991
Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine.
In order to clarify the role of endogenous dopamine in the binding of [3H]SCH23390 and [3H]N-methylspiperone to the mouse… 
1990
1990
Effect of desipramine on dopamine receptor binding in vivo.
1989
1989
Brain dopaminergic mechanisms in Parkinson's disease evaluated by positron emission tomography
Abstract– The meso‐striatal dopamine neurons, essential for the automated control of movements, are primarily affected in… 
Highly Cited
1987
Highly Cited
1987
In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)